Drug shortages are at an all-time high, and while the White House has rolled out a plan to reduce future shortages, it ignores the main cause: the variable quality of America’s generic drug supply, much of which is imported from overseas. The plan does not encourage or require US wholesalers and pharmacy benefits managers to source generic drugs from manufacturers that consistently produce high-quality products.